A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

HL, Chan; NW, Leung; AY, Hui; VW, Wong; CT, Liew; AM, Chim; FK, Chan; LC, Hung; YT, Lee; JS, Tam; CW, Lam; JJ, Sung

doi:10.7326/0003-4819-142-4-200502150-00006

Public

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

Shared by NobleBlocks on Feb 1, 2005 • 12:00 AM UTC

Authors:

Chan HL

Leung NW

Hui AY

Abstract

Background Conventional interferon and lamivudine monotherapy are unsatisfactory in treating hepatitis B virus (HBV) infection.Objective To evaluate the efficacy and safety of pegylated interferon-alpha2b and lamivudine combination therapy for chronic hepatitis B.Design Randomized, controlled, open-...

Discussions